Trials / Completed
CompletedNCT00268554
Enhancement of Postocclusive Reactive Hyperaemia by Dipyridamole
Enhancement of Postocclusive Reactive Hyperaemia
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 12 (estimated)
- Sponsor
- Radboud University Medical Center · Academic / Other
- Sex
- All
- Age
- 18 Years – 50 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to determine whether dipyridamole enhances postocclusive reactive hyperaemia by increasing extracellular adenosine concentrations during ischemia and reperfusion. Furthermore we hypothesize that dipyridamole augments postocclusive reactive hyperaemia by increasing adenosine receptor stimulation.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | dipyridamole | |
| DRUG | caffeine |
Timeline
- Start date
- 2005-12-01
- Completion
- 2006-07-01
- First posted
- 2005-12-22
- Last updated
- 2008-03-28
Locations
1 site across 1 country: Netherlands
Source: ClinicalTrials.gov record NCT00268554. Inclusion in this directory is not an endorsement.